ArisGlobal to Attend and Speak on Regulatory Data at GPRAS in Berlin
In person attendance, speaking session, and LifeSphere Regulatory demos mark ...
Gain the Decision Advantage
Breakthrough 2027 brings together life sciences leaders, industry regulators and experts, to explore the future of AI in life sciences.
In person attendance, speaking session, and LifeSphere Regulatory demos mark ...
MIAMI, FL - March 18, 2022 - ArisGlobal®, the leading ...
ArisGlobal’s signature R&D Safety suite continues to record substantial global ...
Leading automated drug development technology platform LifeSphere recognized for outstanding ...
ArisGlobal’s industry-leading regulatory software chosen by top pharmaceutical company for ...
LifeSphere product leaders share insight into how an effective IDMP ...
Serving as ArisGlobal’s Board Chairman since 2020, Gordon will assume ...
ArisGlobal and Snowflake's partnership will help life science companies seamlessly ...
Industry veteran Dario Lirio to address concerns and provide insights ...
Miami, FL - January 14th, 2022 - ArisGlobal, the leading ...
ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 220 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.
Quick Links
© 2026 ArisGlobal – All Rights Reserved